Skip to main content
Funded Studies

Kevan M. Shokat, PhD

Professor at University of California, San Francisco

HHMI Investigator at Howard Hughes Medical Institute

Location: San Francisco, CA United States

Dr. Kevan Shokat is currently an investigator of the Howard Hughes Medical Institute, vice-chair of and professor in the Department of Cellular and Molecular Pharmacology at the University of California San Francisco (UCSF) and professor in the Department of Chemistry at the University of California Berkeley. He received his BA in chemistry from Reed College in 1986. After receiving his PhD in organic chemistry at UC Berkeley with Professor Peter Schultz, and postdoctoral work in immunology at Stanford University with Professor Chris Goodnow, he began his independent research career at Princeton University before moving to UCSF in 1999. He has been inducted into the National Academy of Sciences (2010), the Institute of Medicine (2011) and the American Academy of Arts and Sciences (2011). He has commercialized discoveries from his laboratory through co-founding several biotechnology companies including, Cellular Genomics, Intellikine, Araxes, Kura, eFFECTOR, Revolution Medicines and Mitokinin.


Associated Grants

  • Inhibition of LRRK2 Roc-COR GTPase

    2019


  • Drug Rescue of PINK1: New Therapeutic Modality for Treating Parkinson’s Disease

    2014


  • Drug Rescue of PINK1 Kinase Activity - A New Therapeutic Modality For Treating PD

    2011


  • Drug Rescue of PINK1 Kinase Activity - A New Therapeutic Modality For Treating PD

    2011


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.